Tonix Pharmaceuticals Holding Corp. (TNXP)

0.5166 +0.0065 (+1.274%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 0.5101

Price Open 0.52

Volume: 2.8M

Avg Volume: 1.45M

Market Cap: 7.34M

P/E Ratio -0.18

52 Wk Range 0.47-5.11



TNXP Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
6.07M
1.17M
1.23
19.25%

2018-09-28
6.07M
581,273
1.99
9.58%

2018-09-14
6.07M
471,753
0.41
7.77%

2018-08-31
6.07M
514,775
0.47
8.48%




TNXP Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-06
Q3 2018
N/A
-0.65 (5)
0.00
0.00

2018-08-13
Q2 2018
N/A
-0.76 (5)
-0.73
0.03

2018-05-21
Q1 2018
N/A
-0.69 (2)
0.00
0.00

2018-05-14
Q1 2018
N/A
-0.70 (3)
-0.88
-0.18

News

Tonix Pharmaceuticals beats by $0.02 (2018-11-09 07:46 SeekingAlpha)

Tonix Pharmaceuticals (NASDAQ: TNXP ): Q3 GAAP EPS of -$0.57 beats by $0.02 . More news on: Tonix Pharmaceuticals Holding Corp., Earnings news and commentary, Healthcare stocks news, , Read more …

 


Statistics

Shares Outstanding: 14.2M

Top 15 Institution Percent: 13.30

Price To Sales: N/A

Price To Book: 0.53

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -103.00

Return On Equity: -113.21

Profit Margin: N/A

Price History

Beta: 1.37

50-day Moving Avg: 0.64

200-day Moving Avg: 2.44

YTD Change: -86.04

5-day Change: -11.10

1-month Change: -12.44

3-month Change: -56.59

6-month Change: -82.37

1-year Change: -85.65

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Tonix Pharmaceuticals Holding Corp.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.